However, many questions are raised about their counterparts that only express GZMK; in our data, these are not cytolytic, have higher basal proliferation in patients with cancer, but do not proliferate after immunotherapy, and adopt a memory phenotype in the periphery. This evidence concerns the gene GZMK and cancer.